SF2a-TT15 Synthetic Carbohydrate-based Conjugate Vaccine
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for SF2a-TT15 Synthetic Carbohydrate-based Conjugate Vaccine, covering 2024-04-23 to 2024-04-23. Get the full timeline:
Most recent: Clinical Trial Update: A Study to Investigate the Safety and Immunogenicity of the SF2a-TT15 Synthetic Carbohydrate-based Conjugate Vaccine Against Shigella Flexneri 2a [Phase 2]